SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-038492
Filing Date
2024-03-25
Accepted
2024-03-25 17:15:23
Documents
2
Group Members
JEREMY C. GREENREDCO II MASTER FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm249643d1_sc13da.htm SC 13D/A 96086
2 EXHIBIT 99.10 tm249643d1_ex99-10.htm EX-99.10 35175
  Complete submission text file 0001104659-24-038492.txt   132927
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87649 | Film No.: 24780144
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)